Cigarette smoking is the leading preventable cause of death and disease in Canada, and is disproportionately more frequent among psychiatric patients. Smoking cessation interventions can be successfully implemented with psychiatric patients, yet no Canadian studies have evaluated smoking prevalence, nicotine dependence, and motivation for smoking cessation in psychiatric inpatients. Our study did so to help plan appropriate interventions for these patients.
Method:
All inpatients aged 18 years or older admitted to acute-care psychiatry units at the Foothills Medical Centre in Calgary, Alberta, during a 6-month period completed a survey involving questions from the Canadian Tobacco Use Monitoring Survey, the Fagerstrom Test for Nicotine Dependence (FTND), the Readiness to Quit Ladder, and the Decisional Balance for Cigarette Smoking. Responses were analyzed for correlation with discharge diagnoses, age, and sex.
Results:
Among the total inpatients (n = 342), 211 (62%) completed the survey. Among those, 55% were current cigarette smokers and 17.5% were former smokers. Nicotine dependence (FTND ≥ 6) was reported in 45.2% of smokers. Smoking prevalence and nicotine dependence severity was greatest in the substance use disorders (SUD) and psychotic disorders groups. Current smokers endorsed more negative than positive attributes of smoking. Regarding smoking cessation, 51% of patients were precontemplative, 12.7% contemplative, and 36.2% preparatory or action-oriented, despite few receiving advice to quit.
Conclusions:
Cigarette smoking and nicotine dependence are highly prevalent in psychiatric inpatients. However, self-reported motivation for smoking cessation is noteworthy, emphasizing that cessation advice and appropriate follow-up care should be provided to psychiatric inpatients who smoke.
BaliunasDPatraJRehmJ, Smoking-attributable mortality and expected years of life lost in Canada 2002: Conclusions for prevention and policy [Internet]. Chronic Dis Can. 2007;27:154–162 [cited 2007 Dec 23]. Available from: http://www.phac-aspc.gc.ca/publicat/cdic-mcc/27–4/pdf/cdic274–3_e.pdf.
4.
IllingEMKaisermanMJ. Mortality attributable to tobacco use in Canada and its regions, 1994 and 1996 [Internet]. Chronic Dis Can. 1999;20:111–117 [cited 2007 Dec 23]. Available from: http://www.phac-aspc.gc.ca/publicat/cdic-mcc/20–3/b_e.html.
JohnsonJLMacDonaldSReistD, Tobacco reduction in the context of mental illness and addictions. A review of the evidence. Vancouver (BC): Centre for Addiction Research of British Columbia; 2006.
7.
BakerAIversRGBowmanJ, Where there's smoke, there's fire: High prevalence of smoking among some sub-populations and recommendations for intervention. Drug Alcohol Rev. 2006;25:85–96.
8.
de LeonJDiazFJ. A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors. Schizophr Res. 2005;75:35–57.
9.
JohnUMeyerCRumpfH, Smoking, nicotine dependence and psychiatric comorbidity—a population-based study including smoking cessation rates after three years. Drug Alcohol Depend. 2004;76:287–295.
10.
BreslauNNovakSPKesslerRC. Psychiatric disorders and stages of smoking. Biol Psychiatry. 2004;55:69–76.
11.
PoirierMCanceilOBayléF.Prevalence of smoking in psychiatric patients. Prog Neuropsychopharmacol Biol Psychiatry. 2002;26:529–537.
12.
BreslauNKilbeyMAndreskiP.Nicotine withdrawal symptoms and psychiatric disorders: Findings from an epidemiologic study of young adults. Am J Psychiatry. 1992;149:464–469.
13.
IsmailKSloggettADe StavolaB.Do common mental disorders increase cigarette smoking? Results from five waves of a population-based panel cohort study. Am J Epidemiol. 2000;152:651–657.
14.
DixonLPostradoLDelahantyJ, The association of medical comorbidity in schizophrenia with poor physical and mental health. J Nerv Ment Dis. 1999:187:496–502.
15.
HurtRDOffordKPCroghanIT, Mortality following inpatient addictions treatment. Role of tobacco use in a community-based cohort. JAMA. 1996;275:1097–1103.
16.
SchmitzNKruseJKuglerJ.Disabilities, quality of life, and mental disorders associated with smoking and nicotine dependence. Am J Psychiatry. 2003;160:1670–1676.
17.
GoffDCSullivanLMMcEvoyJP, A comparison of ten-year cardiac risk estimates in schizophrenia patients from the CATIE study and matched controls. Schizophr Res. 2005;80:45–53.
18.
OliverDLubmanDIFraserR.Tobacco smoking within psychiatric inpatient settings: A biopsychosocial perspective. Aust N Z J Psychiatry. 2007;41:572–580.
19.
LeonardSAdlerLEBenhammouK, Smoking and mental illness. Pharmacol Biochem Behav. 2001;70:561–570.
20.
de LeonJDadvandMCanusoC, Schizophrenia and smoking: An epidemiological survey in a state hospital. Am J Psychiatry. 1995;152:453–455.
21.
de LeonJTracyJMcCannE, Schizophrenia and tobacco smoking: A replication study in another US psychiatric hospital. Schizophr Res. 2002;56:55–65.
22.
de LeonJBecoñaEGurpeguiM, The association between high nicotine dependence and severe mental illness may be consistent across countries. J Clin Psychiatry. 2002;63:812–816.
23.
CarosellaAMOssip-KleinDJOwensCA. Smoking attitudes, beliefs, and readiness to change among acute and long term care inpatients with psychiatric diagnoses. Addict Behav. 1999;24:331–344.
24.
CruceGNordströmLGÖjehagenA.Risky use and misuse of alcohol, drugs and cigarettes detected by screening questionnaires in a clinical psychosis unit. Nord J Psychiatry. 2007;61:92–99.
25.
de LeonJDiazFJRogersT, Initiation of daily smoking and nicotine dependence in schizophrenia and mood disorders. Schizophr Res. 2002;56:47–54.
26.
ÜçokAPolatABozkurtO, Cigarette smoking among patients with schizophrenia and bipolar disorders. Psychiatry Clin Neurosci. 2004;58:434–437.
27.
KillianRBeckerTKrügerK, Health behavior in psychiatric in-patients compared with a German general population sample. Acta Psychiatr Scand. 2006;114:242–248.
28.
ChallisGB. Level of activity and prevalence of smoking in psychiatric patients. Can J Psychiatry. 1999;44:711.
29.
ForchukCNormanRMallaA, Schizophrenia and the motivation for smoking. Perspect Psychiatr Care. 2002;38:41–49.
30.
LuckstedAMcGuireCPostradoL, Specifying cigarette smoking and quitting among people with serious mental illness. Am J Addict. 2004;13:128–138.
31.
MooreDLangloisMGerberBM, Intention to quit tobacco use among clients in substance use disorder treatment settings. Subst Use Misuse. 2007;42:871–879.
32.
HurtRDEbermanKMCroghanIT, Nicotine dependence treatment during inpatient treatment for other addictions: A prospective intervention trial. Alcohol Clin Exp Res. 1994;18:867–872.
33.
AddingtonJEl-GuebalyNCampbellW, Smoking cessation treatment for patients with schizophrenia. Am J Psychiatry. 1998:155:974–976.
34.
AddingtonJ.Group treatment for smoking cessation among persons with schizophrenia. Psychiatr Serv. 1998;49:925–928.
35.
ProchaskaJJDelucchiKHallSM. A meta-analysis of smoking cessation interventions with individuals in substance abuse treatment or recovery. J Consul Clin Psychol. 2004;72:1144–1156.
36.
BoboJK. Tobacco use, problem drinking, and alcoholism. Clin Obstet Gynecol. 2002;45:1169–1180.
37.
BaoYDuanNFoxSA. Is some provider advice on smoking cessation better than no advice? An instrumental variable analysis of the 2001 National Health Interview Survey. Health Serv Res. 2006;41:2114–2135.
38.
ZiedonisDWilliamsJMSmelsonD.Serious mental illness and tobacco addiction: A model program to address this common but neglected issue. Am J Med Sci. 2003;326:223–230.
39.
RigottiNAMunafoMRSteadLF. Interventions for smoking cessation in hospitalised patients. Cochrane Database Syst Rev. 2007;3.
40.
el-GuebalyNCathcartJCurrieS.Public health and therapeutic aspects of smoking bans in mental health and addictions settings. Psychiatr Serv. 2002;53:1617–1622.
41.
ProchaskaJJFletcherLHallSE. Return to smoking following a smoke-free psychiatric hospitalization. Am J Addict. 2006;15:15–22.
42.
HeathertonTFKozlowskiLTFreckerRC, The fagerström test for nicotine dependence: A revision of the fagerström tolerance questionnaire. Br J Addict. 1991;86:1119–1127.
43.
AbramsDNiauraRBrownR, Appendix: Reproducible handouts. In: AbramsDNiauraRBrownR, editors. The tobacco dependence treatment handbook: A guide to best practices. New York (NY). The Guilford Press; 2003. p 299.
44.
VelicerWFDiClementeCCProchaskaJO, Decisional balance measure for assessing and predicting smoking status. J Pers Soc Psychol. 1985;48:1279–1289.
45.
FagerströmKOKunzeMSchoberbergerR, Nicotine dependence versus smoking prevalence: Comparisons among countries and categories of smokers. Tob Control. 1996;5:52–56.
46.
HughesJROlivetoAHRiggsR.Concordance of difference measures of nicotine dependence: Two pilot studies. Addict Behav. 2004;29:1527–1539.
47.
PiperMEMcCarthyDEBakerTB. Assessing tobacco dependence: A guide to measure evaluation and selection. Nicotine Tob Res. 2006;8:339–351.
48.
MoolchanETRadziusAEpsteinDH, The Fagerstrom test for nicotine dependence and the diagnostic interview schedule. Do they diagnose the same smokers?Addict Behav. 2002;27:101–113.
49.
ItkinONemetsBEinatH.Smoking habits in bipolar and schizophrenic outpatients in southern Israel. J Clin Psychiatry. 2001;62:269–272.
50.
AddingtonJEl-GuebalyNAddingtonD, Readiness to stop smoking in schizophrenia. Can J Psychiatry. 1997;42:49–52.
51.
HughesJRHatsukamiDKMitchellJE, Prevalence of smoking among psychiatric outpatients. Am J Psychiatry. 1986;143:993–997.
52.
VanablePACareyMPCareyKB, Smoking among psychiatric outpatients: Relationship to substance use, diagnosis, and illness severity. Psychol Addict Behav. 2003;17:259–265.
53.
ProchaskaJJGillPHallSM. Treatment of tobacco use in an inpatient psychiatric setting. Psychiatr Serv. 2004;55:1265–1270.
54.
KeizerIEytanA.Variations in smoking during hospitalization in psychiatric in-patient units and smoking prevalence in patients and health-care staff. Int J Soc Psychiatry. 2005;51:317–328.
55.
EtterMEtterJ-F.Acceptability and impact of a partial smoking ban in a psychiatric hospital. Prev Med. 2007;44:64–69.
56.
HughesJRHelzerJELindbergSA. Prevalence of DSM/ICD–defined nicotine dependence. Drug Alcohol Depend. 2006;85:91–102.
57.
WilliamsJMZiedonisD.Addressing tobacco among individuals with a mental illness or an addiction. Addict Behav. 2004;29:1067–1083.
FergussonDGoodwinRHorwoodL.Major depression and cigarette smoking: Results of a 21-year longitudinal study. Psychol Med. 2003;33:1357–1367.
60.
Public Health Agency of Canada. Lifestyle behaviours—nicotine dependence. Statistical report on the health of Canadians [Internet]. Ottawa (ON): Public Health Agency of Canada; 1999 [cited 2008 Nov 4]. Available from: http://www.phac-aspc.gc.ca/ph-sp/report-rapport/stat/pdf/eng39–52.pdf.
61.
CohenJEPedersonLLAshleyMJ, Is ‘stage of change’ related to knowledge of health effects and support for tobacco control?Addict Behav. 2002;27:49–61.
62.
ProchaskaJODiClementeCCNorcrossJC. In search of how people change. Applications to addictive behaviors. Am Psychol. 1992;47:1102–1114.
63.
EtterJ-FPernegerTV. Associations between the stages of change and the pros and cons of smoking in a longitudinal study of Swiss smokers. Addict Behav. 1999;24:419–424.
64.
Centres for Disease Control and Prevention. Smoking-cessation advice from health-care providers—Canada, 2005 [Internet]. Ottawa (ON): Morbidity and Mortality Weekly Report CDC; 2007 Jul 20 [cited 2007 Dec 23]. Available from: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5628a3.htm.
65.
LawnSJ. Systemic barriers to quitting smoking among institutionalised public mental health services populations: A comparison of two Australian sites. Int J Soc Psychiatry. 2004;50:204–215.
66.
LawnSCondonJ.Psychiatric nurses' ethical stance on cigarette smoking by patients: Determinants and dilemmas in their role in supporting cessation. Int J Ment Health Nurs. 2006;15:111–118.
67.
LawnSJPolsRGBarberJG. Smoking and quitting: A qualitative study with community-living psychiatric clients. Soc Sci Med. 2002;54:93–104.
68.
LawnSPolsR.Smoking bans in psychiatric inpatient settings? A review of the research. Aust N Z J Psychiatry. 2005;39:866–885.
69.
Calgary Health Region. Tobacco reduction policy evaluation: Creating smoke-free property, 2004 [Internet]. Calgary (AB): Calgary Health Region; 2004 [cited 2008 Apr 21]. Available from: http://www.calgaryhealthregion.ca/programs/tobacco.
70.
KalmanDMorissetteSBGeorgeTP. Co-morbidity of smoking in patients with psychiatric and substance-use disorders. Am J Addict. 2005;14:106–123.
71.
Jané-LlopisEMatytsinaI.Mental health and alcohol, durgs and tobacco: A review of the comorbidity between mental disorders and the use of alcohol, tobacco and illcit drugs. Drug Alcohol Rev. 2006;25:515–536.
72.
ZiedonisDMSmelsonDRosenthalRN, Improving the care of individuals with schizophrenia and substance use disorders: Consensus recommendations. J Psychiatr Pract. 2005;11:315–339.
73.
BaborTFBrownJDelBocaFK. Validity of self-reports in applied research on addictive behaviors: Fact or fiction?Behav Assess. 1990;12:5–31.
74.
GromanEBayerP.A combination of exhaled carbon monoxide (CO) measurement and the Fagerström tests for nicotine dependence (FTND) is recommended to complete information on smoking rates in population-based surveys. Soz Praventivmed. 2000;45:226–228.
